Genfit

GENFIT is a well-established biopharmaceutical company that focuses on the exploration and advancement of innovative therapeutic and diagnostic solutions for metabolic and hepatic ailments with significant unmet medical requirements, corresponding to a deficiency of approved treatments. GENFIT is a pioneer in the area of nuclear receptor-based drug discovery, with an extensive past and robust scientific legacy spanning over two decades. Its most advanced drug candidate is elafibranor.